Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' GISSELBRECHT S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 82 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Constantino, S; Santos, R; Gisselbrecht, S; Gouilleux, F
      The ecdysone inducible gene expression system: unexpected effects of muristerone A and ponasterone A on cytokine signaling in mammalian cells

      EUROPEAN CYTOKINE NETWORK
    2. Ahmed, M; Dusanter-Fourt, I; Dugray, A; Dubrez, L; Novault, S; Bonnet, ML; Gisselbrecht, S; Varet, B; Solary, E; Vainchenker, W; Turhan, AG
      BCR-ABL fails to inhibit apoptosis in U937 myelomonocytic cells expressinga carboxyl-terminal truncated Stat5

      LEUKEMIA & LYMPHOMA
    3. Monni, R; Santos, SCR; Mauchauffe, M; Berger, R; Ghysdael, J; Gouilleux, F; Gisselbrecht, S; Bernard, O; Penard-Lacronique, V
      The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells

      ONCOGENE
    4. Bouscary, D; Lecoq-Lafon, C; Chretien, S; Zompi, S; Fichelson, S; Muller, O; Porteu, F; Dusanter-Fourt, I; Gisselbrecht, S; Mayeux, P; Lacombe, C
      Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo)

      ONCOGENE
    5. Constantino, S; Santos, R; Lacronique, V; Bouchaert, I; Monni, R; Bernard, O; Gisselbrecht, S; Gouilleux, F
      Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway

      ONCOGENE
    6. Garcia, J; de Gunzburg, J; Eychene, A; Gisselbrecht, S; Porteu, F
      Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1-and Rap1-B-Raf-dependent pathways

      MOLECULAR AND CELLULAR BIOLOGY
    7. Santos, SCR; Monni, R; Bouchaert, I; Bernard, O; Gisselbrecht, S; Gouilleux, F; Penard-Lacronique, V
      Involvement of the NF-kappa B pathway in the transforming properties of the TEL-Jak2 leukemogenic fusion protein

      FEBS LETTERS
    8. Soussi, T; Gisselbrecht, S; Blay, JY
      c-Kit, SCFR (stem cell factor receptor) CD117

      BULLETIN DU CANCER
    9. Santos, SCR; Dumon, S; Mayeux, P; Gisselbrecht, S; Gouilleux, F
      Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line

      ONCOGENE
    10. Germani, A; Bruzzoni-Giovanelli, H; Fellous, A; Gisselbrecht, S; Varin-Blank, N; Calvo, F
      SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis

      ONCOGENE
    11. Challier, C; Cocault, L; Flon, M; Pauchard, M; Porteu, F; Gisselbrecht, S; Souyri, M
      A new feature of Mpl receptor: ligand-induced transforming activity in FRErat fibroblasts

      ONCOGENE
    12. Halfon, MS; Carmena, A; Gisselbrecht, S; Sackerson, CM; Jimenez, F; Baylies, MK; Michelson, AM
      Ras pathway specificity is determined by the integration of multiple signal-activated and tissue-restricted transcription factors

      CELL
    13. Verdier, F; Walrafen, P; Hubert, N; Chretien, S; Gisselbrecht, S; Lacombe, C; Mayeux, P
      Proteasomes regulate the duration of erythropoietin receptor activation bycontrolling down-regulation of cell surface receptors

      JOURNAL OF BIOLOGICAL CHEMISTRY
    14. Lacronique, V; Boureux, A; Monni, R; Dumon, S; Mauchauffe, M; Mayeux, P; Gouilleux, F; Berger, R; Gisselbrecht, S; Ghysdael, J; Bernard, OA
      Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells

      BLOOD
    15. Gisselbrecht, S
      The CIS/SOCS proteins: a family of cytokine-inducible regulators of signaling

      EUROPEAN CYTOKINE NETWORK
    16. Dumon, S; Santos, SCR; Debierre-Grockiego, F; Gouilleux-Gruart, V; Cocault, L; Boucheron, C; Mollat, P; Gisselbrecht, S; Gouilleux, F
      IL-3 dependent regulation of Bcl-x(L) gene expression by STAT5 in a bone marrow derived cell line

      ONCOGENE
    17. Gisselbrecht, S
      The CIS-SOCS proteins: a new family of modulators of cytokine signalling

      M S-MEDECINE SCIENCES
    18. Germani, A; Romero, F; Houlard, M; Camonis, J; Gisselbrecht, S; Fischer, S; Varin-Blank, N
      hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways

      MOLECULAR AND CELLULAR BIOLOGY
    19. Gisselbrecht, S
      Relaxing movements

      NEW SCIENTIST
    20. Fontenay-Roupie, M; Bouscary, D; Guesnu, M; Picard, F; Melle, J; Lacombe, C; Gisselbrecht, S; Mayeux, P; Dreyfus, F
      Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction

      BRITISH JOURNAL OF HAEMATOLOGY
    21. Fichelson, S; Freyssinier, JM; Picard, F; Fontenay-Roupie, M; Guesnu, M; Cherai, M; Gisselbrecht, S; Porteu, F
      Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors

      BLOOD
    22. Lecoq-Lafon, C; Verdier, F; Fichelson, S; Chretien, S; Gisselbrecht, S; Lacombe, C; Mayeux, P
      Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase

      BLOOD
    23. Fichelson, S; Chretien, S; Rokicka-Piotrowicz, M; Bouhanik, S; Gisselbrecht, S; Mayeux, P; Lacombe, C
      Tyrosine residues of the erythropoietin receptor are dispensable for erythroid differentiation of human CD34+ progenitors

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    24. AHMED M; DUSANTERFOURT I; BERNARD M; MAYEUX P; HAWLEY RG; BENNARDO T; NOVAULT S; BONNET ML; GISSELBRECHT S; VARET B; TURHAN AG
      BCR-ABL AND CONSTITUTIVELY ACTIVE ERYTHROPOIETIN RECEPTOR (CEPOR) ACTIVATE DISTINCT MECHANISMS FOR GROWTH FACTOR-INDEPENDENCE AND INHIBITION OF APOPTOSIS IN BA F3 CELL-LINE/

      Oncogene
    25. BUFF E; CARMENA A; GISSELBRECHT S; JIMENEZ F; MICHELSON AM
      SIGNALING BY THE DROSOPHILA EPIDERMAL GROWTH-FACTOR RECEPTOR IS REQUIRED FOR THE SPECIFICATION AND DIVERSIFICATION OF EMBRYONIC MUSCLE PROGENITORS

      Development
    26. Michelson, AM; Gisselbrecht, S; Buff, E; Skeath, JB
      Heartbroken is a specific downstream mediator of FGF receptor signalling in Drosophila

      DEVELOPMENT
    27. Carmena, A; Gisselbrecht, S; Harrison, J; Jimenez, F; Michelson, AM
      Combinatorial signaling codes for the progressive determination of cell fates in the Drosophila embryonic mesoderm

      GENES & DEVELOPMENT
    28. FICHELSON S; FREYSSINIER JM; LECOQ C; PICARD F; GISSELBRECHT S; MAYEUX P; LACOMBE C
      PURIFICATION OF A POPULATION OF HUMAN BFU-E FROM CD34-BLOOD CELL-CULTURES( CORD)

      Experimental hematology
    29. VERDIER F; RABIONET R; GOUILLEUX F; BEISENHERZHUSS C; VARLET P; MULLER O; MAYEUX P; LACOMBE C; GISSELBRECHT S; CHRETIEN S
      A SEQUENCE OF THE CIS GENE PROMOTER INTERACTS PREFERENTIALLY WITH 2 ASSOCIATED STAT5A DIMERS - A DISTINCT BIOCHEMICAL DIFFERENCE BETWEEN STAT5A AND STAT5B

      Molecular and cellular biology
    30. GISSELBRECHT S
      WINE INTO WATER

      New scientist
    31. MICHELSON AM; GISSELBRECHT S; ZHOU Y; BAEK KH; BUFF EM
      DUAL FUNCTIONS OF THE HEARTLESS FIBROBLAST GROWTH-FACTOR RECEPTOR IN DEVELOPMENT OF THE DROSOPHILA EMBRYONIC MESODERM

      Developmental genetics
    32. VERDIER F; CHRETIEN S; MULLER O; VARLET P; YOSHIMURA A; GISSELBRECHT S; LACOMBE C; MAYEUX P
      PROTEASOMES REGULATE ERYTHROPOIETIN RECEPTOR AND SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5 (STAT5) ACTIVATION - POSSIBLE INVOLVEMENT OF THE UBIQUITINATED CIS PROTEIN

      The Journal of biological chemistry
    33. ROMERO F; GERMANI A; PUVION E; CAMONIS J; VARINBLANK N; GISSELBRECHT S; FISCHER S
      VAV BINDING TO HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN (HNRNP)-C - EVIDENCE FOR VAV-HNRNP INTERACTIONS IN AN RNA-DEPENDENT MANNER

      The Journal of biological chemistry
    34. Boucheron, C; Dumon, S; Constantino, S; Santos, R; Moriggl, R; Hennighausen, L; Gisselbrecht, S; Gouilleux, F
      A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities

      JOURNAL OF BIOLOGICAL CHEMISTRY
    35. Duprez, V; Blank, U; Chretien, S; Gisselbrecht, S; Mayeux, P
      Physical and functional interaction between p72(syk) and erythropoietin receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    36. CHRETIEN S; DUPREZ V; MAOUCHE L; GISSELBRECHT S; MAYEUX P; LACOMBE C
      ABNORMAL ERYTHROPOIETIN (EPO) GENE-EXPRESSION IN THE MURINE ERYTHROLEUKEMIA IW32 CELLS RESULTS FROM A REARRANGEMENT BETWEEN THE G-PROTEIN BETA-2 SUBUNIT GENE AND THE EPO GENE

      Oncogene
    37. LACRONIQUE V; VARLET P; MAYEUX P; PORTEU A; GISSELBRECHT S; KAHN A; LACOMBE C
      BCL-2 TARGETED OVEREXPRESSION INTO THE ERYTHROID LINEAGE OF TRANSGENIC MICE DELAYS BUT DOES NOT PREVENT THE APOPTOSIS OF EPO-DEPRIVED ERYTHROID PROGENITORS

      Experimental hematology
    38. ROUYEZ MC; BOUCHERON C; GISSELBRECHT S; DUSANTERFOURT I; PORTEU F
      CONTROL OF THROMBOPOIETIN-INDUCED MEGAKARYOCYTIC DIFFERENTIATION BY THE MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY

      Molecular and cellular biology
    39. VERDIER F; CHRETIEN S; BILLAT C; GISSELBRECHT S; LACOMBE C; MAYEUX P
      ERYTHROPOIETIN INDUCES THE TYROSINE PHOSPHORYLATION OF INSULIN-RECEPTOR SUBSTRATE-2 - AN ALTERNATE PATHWAY FOR ERYTHROPOIETIN-INDUCED PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION

      The Journal of biological chemistry
    40. DOUBEIKOVSKI A; UZAN G; DOUBEIKOVSKI Z; PRANDINI MH; PORTEU F; GISSELBRECHT S; DUSANTERFOURT I
      THROMBOPOIETIN-INDUCED EXPRESSION OF THE GLYCOPROTEIN IIB GENE INVOLVES THE TRANSCRIPTION FACTOR PU.1 SPI-1 IN UT7-MPL CELLS/

      The Journal of biological chemistry
    41. LACRONIQUE V; VARLET P; MAYEUX P; PORTEU A; GISSELBRECHT S; KAHN A; LACOMBE C
      BCL-2 TARGETED OVEREXPRESSION INTO THE ERYTHROID LINEAGE OF TRANSGENIC MICE DELAYS BUT DOES NOT PREVENT THE APOPTOSIS OF ERYTHROPOIETIN-DEPRIVED ERYTHROID PROGENITORS

      Blood
    42. CHALLIER C; COCAULT L; GISSELBRECHT S; SOUYRI M
      THE THROMBOPOIETIN RECEPTOR, MPL, IS ABLE TO TRANSFORM RAT FIBROBLASTS IN THE PRESENCE OF TPO

      Blood
    43. CHRETIEN S; DUPREZ V; MAOUCHE L; GISSELBRECHT S; MAYEUX P; LACOMBE C
      ERYTHROPOIETIN (EPO) GENE-EXPRESSION IN THE MURINE ERYTHROLEUKEMIA IW32 CELLS RESULTS FROM A REARRANGEMENT BETWEEN THE G-PROTEIN BETA-2 SUBUNIT GENE AND THE EPO GENE

      Blood
    44. AHMED M; DUSANTERFOURT I; MAYEUX P; NOVAULT S; BONNET ML; GISSELBRECHT S; VARET B; TURHAN AG
      THE ANTI-APOPTOTIC POTENTIAL OF BCR-ABL CORRELATES WITH ACTIVATION OFSTAT FACTORS

      Blood
    45. LACOMBE C; LACRONIQUE V; VARLET P; MAYEUX P; PORTEU A; KAHN A; GISSELBRECHT S
      BCL-2 TARGETED OVEREXPRESSION INTO THE ERYTHROID LINEAGE OF TRANSGENIC MICE

      Blood
    46. VERDIER F; CHRETIEN S; BILLAT C; GISSELBRECHT S; LACOMBE C; MAYEUX P
      ERYTHROPOIETIN (EPO) INDUCES THE TYROSINE PHOSPHORYLATION OF THE INSULIN-RECEPTOR SUBSTRATE-2 (IRS-2) - AN ALTERNATE PATHWAY FOR EPO-INDUCED PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION

      Blood
    47. FICHELSON S; ROKICKAPIOTROWICZ M; BOUHANIK S; CHRETIEN S; MAYEUX P; GISSELBRECHT S; LACOMBE C
      RETROVIRUS-MEDIATED GENE-TRANSFER OF THE PROLACTIN RECEPTOR AND OF CHIMERIC PROLACTIN ERYTHROPOIETIN RECEPTORS INDUCES ERYTHROID-DIFFERENTIATION OF CD34+ PROGENITORS/

      Blood
    48. GISSELBRECHT S; SKEATH JB; DOE CQ; MICHELSON AM
      HEARTLESS ENCODES A FIBROBLAST GROWTH-FACTOR RECEPTOR (DFR1 DFGF-R2) INVOLVED IN THE DIRECTIONAL MIGRATION OF EARLY MESODERMAL CELLS IN THEDROSOPHILA EMBRYO/

      Genes & development
    49. LACOMBE C; VARLET P; VERDIER F; GOBERT S; CARTRON JP; GISSELBRECHT S; MAYEUX P; CHRETIEN S
      ERYTHROPOIETIN-INDUCED ERYTHROID-DIFFERENTIATION OF THE HUMAN ERYTHROLEUKEMIA CELL-LINE TF-1 CORRELATES WITH IMPAIRED STAT5 ACTIVATION

      Experimental hematology
    50. PORTEU F; ROUYEZ MC; COCAULT L; BENIT L; CHARON M; PICARD F; GISSELBRECHT S; SOUYRI M; DUSANTERFOURT I
      FUNCTIONAL REGIONS OF THE MOUSE THROMBOPOIETIN RECEPTOR CYTOPLASMIC DOMAIN - EVIDENCE FOR A CRITICAL REGION WHICH IS INVOLVED IN DIFFERENTIATION AND CAN BE COMPLEMENTED BY ERYTHROPOIETIN

      Molecular and cellular biology
    51. ROMERO F; DARGEMONT C; POZO F; REEVES WH; CAMONIS J; GISSELBRECHT S; FISCHER S
      P95(VAV) ASSOCIATES WITH THE NUCLEAR-PROTEIN KU-70

      Molecular and cellular biology
    52. CHRETIEN S; VARLET P; VERDIER F; GOBERT S; CARTRON JP; GISSELBRECHT S; MAYEUX P; LACOMBE C
      ERYTHROPOIETIN-INDUCED ERYTHROID-DIFFERENTIATION OF THE HUMAN ERYTHROLEUKEMIA CELL-LINE TF-1 CORRELATES WITH IMPAIRED STAT5 ACTIVATION

      EMBO journal
    53. GOBERT S; CHRETIEN S; GOUILLEUX F; MULLER O; PALLARD C; DUSANTERFOURT I; GRONER B; LACOMBE C; GISSELBRECHT S; MAYEUX P
      IDENTIFICATION OF TYROSINE RESIDUES WITHIN THE INTRACELLULAR DOMAIN OF THE ERYTHROPOIETIN RECEPTOR CRUCIAL FOR STAT5 ACTIVATION

      EMBO journal
    54. COCAULT L; BOUSCARY D; KERDILES CL; CLAY D; PICARD F; GISSELBRECHT S; SOUYRI M
      ECTOPIC EXPRESSION OF MURINE TPO RECEPTOR (C-MPL) IN MICE IS PATHOGENIC AND INDUCES ERYTHROBLASTIC PROLIFERATION

      Blood
    55. CHRETIEN S; VERDIER F; VARLET P; GOBERT S; DEVERMY E; BILLAT C; GISSELBRECHT S; MAYEUX P; LACOMBE C
      IDENTIFICATION OF STAT PROTEINS ACTIVATED BY ERYTHROPOIETIN IN NORMALERYTHROID PROGENITORS AND IN MURINE AND HUMAN ERYTHROLEUKEMIA

      Blood
    56. EYCHENE A; DUSANTERFOURT I; BARNIER JV; PAPIN C; CHARON M; GISSELBRECHT S; CALOTHY G
      EXPRESSION AND ACTIVATION OF B-RAF KINASE ISOFORMS IN HUMAN AND MURINE LEUKEMIA-CELL LINES

      Oncogene
    57. BOUSCARY D; PREUDHOMME C; RIBRAG V; MELLE J; VIGUIE F; PICARD F; GUESNU M; FENAUX P; GISSELBRECHT S; DREYFUS F
      PROGNOSTIC VALUE OF C-MPL EXPRESSION IN MYELODYSPLASTIC SYNDROMES

      Leukemia
    58. PALLARD C; GOUILLEUX F; BENIT L; COCAULT L; SOUYRI M; LEVY D; GRONER B; GISSELBRECHT S; DUSANTERFOURT I
      THROMBOPOIETIN ACTIVATES A STAT5-LIKE FACTOR IN HEMATOPOIETIC-CELLS

      EMBO journal
    59. DEPARSEVAL N; BORDEREAUX D; VARLET P; GISSELBRECHT S; SOLA B
      ISOLATION OF NEW ONCOGENIC FORMS OF THE MURINE C-FMS GENE

      Journal of virology
    60. COURTOIS G; BENIT L; MIKAELOFF Y; PAUCHARD M; CHARON M; VARLET P; GISSELBRECHT S
      CONSTITUTIVE ACTIVATION OF A VARIANT OF THE ENV-MPL ONCOGENE PRODUCT BY DISULFIDE-LINKED HOMODIMERIZATION

      Journal of virology
    61. FICHELSON S; VIGON I; DUSANTER I; CHARON M; VELU T; BAILLOU C; GISSELBRECHT S; LEMOINE FM
      IN-VITRO TRANSFORMATION OF MURINE PRO-B AND PRE-B CELLS BY V-MPL, A TRUNCATED FORM OF A CYTOKINE RECEPTOR

      The Journal of immunology
    62. PALLARD C; GOUILLEUX F; CHARON M; GRONER B; GISSELBRECHT S; DUSANTERFOURT I
      INTERLEUKIN-3, ERYTHROPOIETIN, AND PROLACTIN ACTIVATE A STAT5-LIKE FACTOR IN LYMPHOID-CELLS

      The Journal of biological chemistry
    63. GOBERT S; DUPREZ V; LACOMBE C; GISSELBRECHT S; MAYEUX P
      THE SIGNAL-TRANSDUCTION PATHWAY OF ERYTHROPOIETIN INVOLVES 3 FORMS OFMITOGEN-ACTIVATED PROTEIN (MAP) KINASE IN UT7 ERYTHROLEUKEMIA-CELLS

      European journal of biochemistry
    64. MORELLA KK; BRUNO E; KUMAKI S; LAI CF; FU J; WANG HM; MURRAY L; HOFFMAN R; TIMOUR M; BENIT L; GISSELBRECHT S; ZHUANG HM; WOJCHOWSKI DM; BAUMANN H; GEARING DP
      SIGNAL-TRANSDUCTION BY THE RECEPTORS FOR THROMBOPOIETIN (C-MPL) AND INTERLEUKIN-3 IN HEMATOPOIETIC AND NONHEMATOPOIETIC CELLS

      Blood
    65. GOBERT S; PORTEU F; PALLU S; MULLER O; SABBAH M; DUSANTERFOURT I; COURTOIS G; LACOMBE C; GISSELBRECHT S; MAYEUX P
      TYROSINE PHOSPHORYLATION OF THE ERYTHROPOIETIN RECEPTOR - ROLE FOR DIFFERENTIATION AND MITOGENIC SIGNAL-TRANSDUCTION

      Blood
    66. GOBERT S; CHRETIEN S; GOUILLEUX F; MULLER O; PALLARD C; DUSANTERFOURT I; GRONER B; LACOMBE C; GISSELBRECHT S; MAYEUX P
      IDENTIFICATION OF TYROSINE RESIDUES WITHIN THE INTRACELLULAR DOMAIN OF THE ERYTHROPOIETIN RECEPTOR CRUCIAL FOR STAT5 ACTIVATION

      Blood
    67. SOUYRI M; COCAULT L; PICARD F; MAYEUX P; LACOMBE C; LAKOMSKI D; BOUSCARY D; GISSELBRECHT S
      INTRODUCTION OF THE MURINE MPL RECEPTOR IN THE PLURIPOTENT HUMAN LEUKEMIC-CELL LINE UT7 - BALANCED EFFECTS OF TPO AND EPO

      Blood
    68. DUSANTERFOURT I; MAYEUX P; GISSELBRECHT S
      CYTOKINE RECEPTORS AND SIGNAL-TRANSDUCTIO N

      MS. Medecine sciences
    69. LEVY ER; JAMES L; LEWIS S; PARGANAS E; GAJJAR A; GISSELBRECHT S; IHLE JN; BUCKLE VJ
      LOCALIZATION OF EVI1 AND FIM3 TO 3Q26

      Cytogenetics and cell genetics
    70. DUSANTERFOURT I; MULLER O; ZIEMIECKI A; MAYEUX P; DRUCKER B; DJIANE J; WILKS A; HARPUR AG; FISCHER S; GISSELBRECHT S
      IDENTIFICATION OF JAK PROTEIN-TYROSINE KINASES AS SIGNALING MOLECULESFOR PROLACTIN - FUNCTIONAL-ANALYSIS OF PROLACTIN RECEPTOR AND PROLACTIN ERYTHROPOIETIN RECEPTOR CHIMERA EXPRESSED IN LYMPHOID-CELLS

      EMBO journal
    71. MAYEUX P; PALLU S; GOBERT S; LACOMBE C; GISSELBRECHT S
      STRUCTURE OF THE ERYTHROPOIETIN RECEPTOR

      Proceedings of the Society for Experimental Biology and Medicine
    72. MEIKRANTZ W; GISSELBRECHT S; TAM SW; SCHLEGEL R
      ACTIVATION OF CYCLIN A-DEPENDENT PROTEIN-KINASES DURING APOPTOSIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    73. BENIT L; COURTOIS G; CHARON M; VARLET P; DUSANTERFOURT I; GISSELBRECHT S
      CHARACTERIZATION OF MPL CYTOPLASMIC DOMAIN SEQUENCES REQUIRED FOR MYELOPROLIFERATIVE LEUKEMIA-VIRUS PATHOGENICITY

      Journal of virology
    74. GOBERT S; DUPREZ V; LACOMBE C; GISSELBRECHT S; MAYEUX P
      ERYTHROPOIETIN INDUCES THE ACTIVATION OF 3 FORMS OF MAP KINASES IN UT7 CELLS

      Blood
    75. GOBERT S; DUSSANTERFOURT I; COURTOIS G; LACOMBE C; GISSELBRECHT S; MAYEUX P
      TYROSINE PHOSPHORYLATION OF THE ERYTHROPOIETIN RECEPTOR - ROLE FOR MITOGENIC SIGNAL-TRANSDUCTION AND PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION

      Blood
    76. CHRETIEN S; MOREAUGACHELIN F; APIOU F; COURTOIS G; MAYEUX P; DUTRILLAUX B; CARTRON JP; GISSELBRECHT S; LACOMBE C
      PUTATIVE ONCOGENIC ROLE OF THE ERYTHROPOIETIN RECEPTOR IN MURINE AND HUMAN ERYTHROLEUKEMIA-CELLS

      Blood
    77. LEVY ER; PARGANAS E; MORISHITA K; FICHELSON S; JAMES L; OSCIER D; GISSELBRECHT S; IHLE JN; BUCKLE VJ
      DNA REARRANGEMENTS PROXIMAL TO THE EVI1 LOCUS ASSOCIATED WITH THE 3Q21Q26 SYNDROME

      Blood
    78. VIGON I; FLORINDO C; FICHELSON S; GUENET JL; MATTEI MG; SOUYRI M; COSMAN D; GISSELBRECHT S
      CHARACTERIZATION OF THE MURINE MPL PROTOONCOGENE, A MEMBER OF THE HEMATOPOIETIC CYTOKINE RECEPTOR FAMILY - MOLECULAR-CLONING, CHROMOSOMAL LOCATION AND EVIDENCE FOR A FUNCTION IN CELL-GROWTH

      Oncogene
    79. MAYEUX P; DUSANTERFOURT I; MULLER O; MAUDUIT P; SABBAH M; DRUKER B; VAINCHENKER W; FISCHER S; LACOMBE C; GISSELBRECHT S
      ERYTHROPOIETIN INDUCES THE ASSOCIATION OF PHOSPHATIDYLINOSITOL 3'-KINASE WITH A TYROSINE-PHOSPHORYLATED PROTEIN COMPLEX CONTAINING THE ERYTHROPOIETIN RECEPTOR

      European journal of biochemistry
    80. VIGON I; DREYFUS F; MELLE J; VIGUIE F; RIBRAG V; COCAULT L; SOUYRI M; GISSELBRECHT S
      EXPRESSION OF THE C-MPL PROTOONCOGENE IN HUMAN HEMATOLOGIC MALIGNANCIES

      Blood
    81. LACOMBE C; CHRETIEN S; MOREAUGACHELIN F; APIOU F; COURTOIS G; MAYEUX P; DUTRILLAUX B; CARTRON JP; GISSELBRECHT S
      PUTATIVE ONCOGENIC ROLE OF THE ERYTHROPOIETIN RECEPTOR IN MURINE AND HUMAN ERYTHROLEUKEMIA-CELLS

      Blood
    82. FICHELSON S; VIGON I; CHARON M; DUSANTER I; BAILLOU CI; GISSELBRECHT S; LEMOINE FM
      IN-VITRO TRANSFORMATION OF MURINE PRE-B CELLS BY V-MPL - A CONSTITUTIVELY ACTIVATED FORM OF A CYTOKINE RECEPTOR

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 13:02:36